Bio Tech Winners

Veracyte Announces New Preliminary Data for Its In-Development Lung Cancer Portfolio Tests

3 years ago

[#item_full_content]

Veracyte Announces New Data Reinforcing Foundational Technology of Nasal Swab Test for Early Lung Cancer Detection Presented at CHEST Annual Meeting 2020
Date
October 19, 2020
In relation to
Similar post
Veracyte Announces Next-Generation Percepta Genomic Sequencing Classifier Now Available to Physicians for Improved Lung Cancer Diagnosis
Date
June 26, 2019
In relation to
Similar post
Veracyte Announces Data Showing Percepta Genomic Atlas Detects Gene Alterations Targeted in Lung Cancer Treatment, Using Diagnostic Biopsy
Date
May 14, 2021
In relation to
Similar post

Bio Tech Winners

Exit mobile version